Literature DB >> 15105136

Mechanisms of azole resistance in petite mutants of Candida glabrata.

Sophie Brun1, Thierry Bergès, Pascal Poupard, Carole Vauzelle-Moreau, Gilles Renier, Dominique Chabasse, Jean-Philippe Bouchara.   

Abstract

We previously showed that resistant colonies of Candida glabrata inside the azole inhibition zones had respiratory deficiency due to mutations in mitochondrial DNA. Here, we analyzed the mechanisms of azole resistance in petite mutants of C. glabrata obtained by exposure to fluconazole or induced by ethidium bromide. The respiratory deficiency of these mutants was confirmed by oxygraphy and flow cytometric analysis with rhodamine 123, and its mitochondrial origin was demonstrated by transmission electron microscopy and restriction endonuclease analysis of the mitochondrial DNA. Flow cytometry with rhodamine 6G suggested an increased drug efflux in mutant cells, which was further supported by Northern blot analysis of the expression of the C. glabrata CDR1 (CgCDR1) and CgCDR2 genes, encoding efflux pumps. Conversely, the expression of CgERG11, which encodes the azole target, was not affected by petite mutations, and no differences were seen in the sequence of this gene between parent isolates and mutants. Moreover, sterol analysis showed similar overall amount of sterols in parent and mutant cells, but quantitative modifications were observed in the mutants, with almost undetectable biosynthesis intermediates. Further analysis performed after separation of free sterols from steryl esters revealed a defect in sterol esterification in mutant cells, with free ergosterol representing 92% of the overall sterol content. Thus, resistance or decreased susceptibility to azoles in petite mutants of C. glabrata is associated with increased expression of CgCDR1 and, to a lesser extent, of CgCDR2. In addition, the marked increase in free ergosterol content would explain their increased susceptibility to polyenes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105136      PMCID: PMC400549          DOI: 10.1128/AAC.48.5.1788-1796.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.

Authors:  D Sanglard; F Ischer; D Calabrese; P A Majcherczyk; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Interorganellar communication. Altered nuclear gene expression profiles in a yeast mitochondrial dna mutant.

Authors:  A Traven; J M Wong; D Xu; M Sopta; C J Ingles
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

3.  Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.

Authors:  D Sanglard; F Ischer; J Bille
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  Heme-regulated expression of two yeast acyl-CoA:sterol acyltransferases is involved in the specific response of sterol esterification to anaerobiosis.

Authors:  Martin Valachovic; Vlasta Klobucníková; Peter Griac; Ivan Hapala
Journal:  FEMS Microbiol Lett       Date:  2002-01-02       Impact factor: 2.742

5.  Transcriptional regulation of the two sterol esterification genes in the yeast Saccharomyces cerevisiae.

Authors:  K Jensen-Pergakes; Z Guo; M Giattina; S L Sturley; M Bard
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

6.  Studies on the mechanism of action of miconazole: effect of miconazole on respiration and cell permeability of Candida albicans.

Authors:  K H Sreedhara Swamy; M Sirsi; G R Ramananda Rao
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

7.  Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.

Authors:  M Martínez; J L López-Ribot; W R Kirkpatrick; S P Bachmann; S Perea; M T Ruesga; T F Patterson
Journal:  J Antimicrob Chemother       Date:  2002-03       Impact factor: 5.790

8.  Mutations in yeast ARV1 alter intracellular sterol distribution and are complemented by human ARV1.

Authors:  A H Tinkelenberg; Y Liu; F Alcantara; S Khan; Z Guo; M Bard; S L Sturley
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

9.  In-vivo selection of an azole-resistant petite mutant of Candida glabrata.

Authors:  Jean-Philippe Bouchara; Rachid Zouhair; Sandrine LE Boudouil; Gilles Renier; Robert Filmon; Dominique Chabasse; Jean-Noel Hallet; Alain Defontaine
Journal:  J Med Microbiol       Date:  2000-11       Impact factor: 2.472

10.  Anaerobiosis induces complex changes in sterol esterification pattern in the yeast Saccharomyces cerevisiae.

Authors:  M Valachovic; L Hronská; I Hapala
Journal:  FEMS Microbiol Lett       Date:  2001-04-01       Impact factor: 2.742

View more
  60 in total

1.  Cell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the Host.

Authors:  Ana C Mesa-Arango; Cristina Rueda; Elvira Román; Jessica Quintin; María C Terrón; Daniel Luque; Mihai G Netea; Jesus Pla; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

2.  Identification of Azole Resistance Markers in Clinical Isolates of Candida tropicalis Using cDNA-AFLP Method.

Authors:  Ali Kanani; Farideh Zaini; Parivash Kordbacheh; Mehraban Falahati; Sassan Rezaie; Roshanak Daie; Shirin Farahyar; Mahin Safara; Roohollah Fateh; Ebrahim Faghihloo; Azam Fattahi; Mansour Heidari
Journal:  J Clin Lab Anal       Date:  2015-04-14       Impact factor: 2.352

3.  Mitochondrial sorting and assembly machinery subunit Sam37 in Candida albicans: insight into the roles of mitochondria in fitness, cell wall integrity, and virulence.

Authors:  Yue Qu; Branka Jelicic; Filomena Pettolino; Andrew Perry; Tricia L Lo; Victoria L Hewitt; Farkad Bantun; Traude H Beilharz; Anton Y Peleg; Trevor Lithgow; Julianne T Djordjevic; Ana Traven
Journal:  Eukaryot Cell       Date:  2012-01-27

Review 4.  Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms.

Authors:  Galina I Lepesheva; Michael R Waterman
Journal:  Biochim Biophys Acta       Date:  2006-08-02

5.  A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.

Authors:  Shaoji Cheng; Cornelius J Clancy; Katherine T Nguyen; William Clapp; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

Review 6.  Will resistance in fungi emerge on a scale similar to that seen in bacteria?

Authors:  H Hof
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-19       Impact factor: 3.267

7.  The lysine biosynthetic enzyme Lys4 influences iron metabolism, mitochondrial function and virulence in Cryptococcus neoformans.

Authors:  Eunsoo Do; Minji Park; Guanggan Hu; Mélissa Caza; James W Kronstad; Won Hee Jung
Journal:  Biochem Biophys Res Commun       Date:  2016-06-25       Impact factor: 3.575

Review 8.  Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy.

Authors:  Miguel Shingu-Vazquez; Ana Traven
Journal:  Eukaryot Cell       Date:  2011-09-16

9.  Functional characterization of the CgPGS1 gene reveals a link between mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata.

Authors:  Monika Batova; Silvia Borecka-Melkusova; Maria Simockova; Vladimira Dzugasova; Eduard Goffa; Julius Subik
Journal:  Curr Genet       Date:  2008-03-15       Impact factor: 3.886

10.  Structural and functional study of YER067W, a new protein involved in yeast metabolism control and drug resistance.

Authors:  Tatiana Domitrovic; Guennadi Kozlov; João Claudio Gonçalves Freire; Claudio Akio Masuda; Marcius da Silva Almeida; Mónica Montero-Lomeli; Georgia Correa Atella; Edna Matta-Camacho; Kalle Gehring; Eleonora Kurtenbach
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.